What is the most appropriate breast-cancer screening interval for women aged 45 to 49 years in New Zealand?
To review the international evidence on the benefits and harms of different screening intervals for women aged 45 to 49 years, and to inform the development of a national policy. A systematic search and review of the literature, up to March 2005. There is no robust trial evidence on which to base a decision on the most appropriate breast-cancer screening interval for women aged 45 to 49 years, and it is unlikely that definitive trial evidence will ever emerge. Evidence from less robust studies is equivocal. In the absence of definitive evidence, those charged with determining the screening interval for women aged 45 to 49 years in a breast-cancer screening programme have to weigh up the available evidence, and consider it alongside other relevant factors. A two-yearly screening interval for women aged 45 to 49 was decided upon, and became policy in New Zealand.